• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Clearmind Medicine Inc (NQ: CMND )

    1.390 -0.070 (-4.79%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Clearmind Medicine Inc

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    SciSparc and Clearmind Collaboration Continues to Increase its Patent Portfolio in the Field of Movement Abnormalities in the U.S.
    From SciSparc Ltd
    Via GlobeNewswire
    EXCLUSIVE: Clearmind Medicine Files US Patent Application For Dyskinesia Treatment, Strengthening Its IP Portfolio
    Clearmind Medicine Inc (NASDAQ: CMND) has announced the filing of a provisional patent application for the treatment of Dyskinesia with the United States Patent and Trademark Office (USPTO) as part of... 
    Via Benzinga
    Clearmind Medicine Announces Share-Based Payment for the Company's Consultants
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Dr. Fatima Cody Stanford, Associate Professor of Medicine and Pediatrics at Harvard Medical School, Joins Clearmind Medicine's Scientific Advisory Board
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Why Is IN8bio (INAB) Stock Up 9% Today?
    IN8bio (INAB) stock is rising higher on Wednesday as the biopharmaceutical company's shares continue their wild swings this week. 
    Via InvestorPlace
    Clearmind Medicine and SciSparc to Conduct Study Evaluating Combination Treatment for Obesity and Metabolic Syndrome
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    SciSparc and Clearmind Medicine to Conduct a Study Evaluating Their Combination Treatment for Obesity and Metabolic Syndrome
    From SciSparc Ltd
    Via GlobeNewswire
    Exclusive: Clearmind And SciSparc To Conduct Study Evaluating Psychedelics And CannAmide Based Drug For Treatment Of Obesity And Metabolic Syndrome
    Clearmind Medicine Inc. (NASDAQ: CMND) (CSE:CMND) (FSE:CWY) announced that as part of the company's ongoing collaboration with SciSparc Ltd. 
    Via Benzinga
    Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    MEAI Compound's First Clinical Trial In US, Clearmind Enters NASDAQ Compliance Period
    Clearmind Medicine Inc. (NASDAQ: CMND), an Israel-based biotech company advancing the clinical stage for an MEAI-based compound targeting Alcohol Use Disorder (AUD,) has selected Yale School of... 
    Via Benzinga
    Clearmind Medicine Announces First US Site for its Phase I/IIa Clinical Trial Evaluating CMND-100 in Patients with Alcohol Use Disorder
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Why DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
    Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares surged 163.7% to $30.98 in pre-market trading after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of... 
    Via Benzinga
    Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
    Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffiths... 
    Via Benzinga
    Benzinga Pro's Top 5 Stocks To Watch For Friday, May 12, 2023: CMCSA, KR, ON, TSVT, CMND
    Comcast (CMCSA) - The parent company of NBCUniversal. One of Friday's most-discussed stories stemmed from a tweet by Elon Musk he had found a new exec to file the chief exec role at Twitter. 
    Via Benzinga
    Clearmind Medicine Announces IRB Approval to Conduct Clinical Trial on Alcohol Use Disorder
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    EXCLUSIVE: Clearmind Medicine Secures Approval To Launch Clinical Trial For Alcohol Addiction Treatment
    Clearmind Medicine Inc. 
    Via Benzinga
    Clearmind Medicine Retains Crescendo Communications LLC. for Investor Relations and Announces Granting of Stock and Warrants
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
    EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations 
    Via Benzinga
    Clearmind Medicine Strengthens Scientific Advisory Board with Appointment of Prof. Joseph Tam
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Next-Gen Israeli Psychedelics Company Gears Up For Trial Targeting Alcohol Addiction
    Alcohol Use Disorder (AUD) is one of the top-targeted health issues by biopharma companies. In the case of Clearmind Medicine (NASDAQ: CMND), the Israel-based company is going at it through its... 
    Via Benzinga
    Clearmind Medicine Announces Clinical Supply Agreement for its Upcoming Clinical Trial
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its... 
    Via Benzinga
    Clearmind Medicine Forms a Data and Safety Monitoring Board to Oversee its First-in-Human Clinical Trial
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Why Meta Platforms Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
    Gainers 
    Via Benzinga
    Why Chipotle Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 105% to $0.1730 after the company issued a letter to shareholders. 
    Via Benzinga
    Why Is ZyVersa Therapeutics (ZVSA) Stock Down 46% Today?
    ZyVersa Therapeutics (ZVSA) stock is sliding lower on Wednesday following a couple of announcements from the biopharmaceutical company. 
    Via InvestorPlace
    Why Bed Bath & Beyond Shares Are Trading Lower By 23%; Here Are 20 Stocks Moving Premarket
    Gainers 
    Via Benzinga
    Why Is Clearmind Medicine (CMND) Stock Up 45% Today?
    Clearmind Medicine (CMND) stock is taking off on Wednesday even without any recent news from the psychedelic medicine company. 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.